Ce. Parr et al., CLONING AND EXPRESSION OF A HUMAN-P(2U) NUCLEOTIDE RECEPTOR, A TARGETFOR CYSTIC-FIBROSIS PHARMACOTHERAPY, Proceedings of the National Academy of Sciences of the United Statesof America, 91(8), 1994, pp. 3275-3279
The Cl- secretory pathway that is defective in cystic fibrosis (CF) ca
n be bypassed by an alternative pathway for Cl- transport that is acti
vated by extracellular nucleotides. Accordingly, the P2 receptor that
mediates this effect is a therapeutic target for improving Cl- secreti
on in CF patients. In this paper, we report the sequence and functiona
l expression of a cDNA cloned from human airway epithelial (CF/T43) ce
lls that encodes a protein with properties of a P2U nucleotide recepto
r. With a retrovirus system, the human airway clone was stably express
ed in 1321N1 astrocytoma cells, a human cell line unresponsive to extr
acellular nucleotides. Studies of inositol phosphate accumulation and
intracellular Ca2+ mobilization induced by extracellular nucleotides i
n 1321N1 cells expressing the receptor identified this done as the tar
get receptor in human airway epithelia. In addition, we independently
isolated an identical cDNA from human colonic epithelial (HT-29) cells
, indicating that this is the same P2U receptor that has been function
ally identified in other human tissues. Expression of the human P2U re
ceptor (HP2U) in 1321N1 cells revealed evidence for autocrine ATP rele
ase and stimulation of transduced receptors. Thus, HP2U expression in
the 1321N1 cell line will be useful for studying autocrine regulatory
mechanisms and in screening of potential therapeutic drugs.